Eating disorders are seen frequently in the clinic, reflecting a combined prevalence in women for anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED) of about 3.5% for the full disorder and 6% if subthreshold disorders are included (Hudson et al. 2007). Males are affected less frequently; about 10% of all cases of AN and BN are in males, with the proportion rising to about 30% for BED in clinical samples. Because much comorbid psychopathology is associated with each of these disorders, including current major depression in about 25% of cases, the treatment plan must take any such disorders into account. Two forms of treatment, psychopharmacological and psychotherapeutic, are effective in the treatment of BN and BED, and possibly in AN. Hence, determining how to sequence or combine treatment modalities is an important issue.